VanEck Biotech ETF (BBH)
162.13
-2.45 (-1.49%)
At close: Mar 03, 2025, 3:58 PM
162.46
0.20%
After-hours: Mar 03, 2025, 04:15 PM EST
No 1D chart data available
| Bid | 158.16 |
| Market Cap | 397.02M |
| AUM | 449.01M |
| NAV | 175.63 |
| EPS (ttm) | 5.31 |
| PE Ratio (ttm) | 30.51 |
| Shares Out | 2.45M |
| Inception Date | Nov 23, 1999 |
| Ask | 165.53 |
| Volume | 4.42K |
| Open | 163.53 |
| Previous Close | 164.58 |
| Day's Range | 162.13 - 163.53 |
| 52-Week Range | 151.35 - 183.64 |
| Holdings | 27 |
| Expense Ratio | 0.35% |
About BBH
The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The Biotech Index includes common stocks and depositary receipts of U.S. exchange-listed companies in the biotechnology industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.
Asset Class Equity
Ticker Symbol BBH
Inception Date Nov 23, 1999
Provider Vaneck
Website Fund Home Page
Top 10 Holdings 72.92% of assets
| Name | Symbol | Weight |
|---|---|---|
| Amgen Inc. | 17.49% | |
| Gilead Sciences, Inc... | 13.86% | |
| Vertex Pharmaceutica... | 11.85% | |
| Regeneron Pharmaceut... | 6.19% | |
| Argenx Se | 5.17% | |
| Iqvia Holdings Inc. | 4.24% | |
| Natera, Inc. | 4.18% | |
| Alnylam Pharmaceutic... | 3.77% | |
| Icon Public Limited ... | 3.16% | |
| Biogen Inc. | 3.01% |
Dividends Dividend Yield 0.79%
| Ex-Dividend | Amount | Payment Date |
|---|---|---|
| Dec 23, 2024 | $1.2517 | Dec 24, 2024 |
| Dec 18, 2023 | $0.7127 | Dec 22, 2023 |
| Dec 19, 2022 | $0.7488 | Dec 23, 2022 |
| Dec 20, 2021 | $0.3972 | Dec 27, 2021 |
| Dec 21, 2020 | $0.6079 | Dec 28, 2020 |
